prion-like behaviour tau-dependent cytotoxicity pyroglutamylated amyloid-beta
extracellular plaques amyloid-beta intraneuronal neurofibrillary tangles made tau histopathological signatures alzheimers disease plaques comprise amyloid-beta fibrils assemble monomeric oligomeric intermediates prognostic indicators alzheimers disease despite importance plaques alzheimers disease oligomers considered principal toxic forms amyloid-beta interestingly many adverse responses amyloid-beta cytotoxicity microtubule loss impaired memory learning neuritic degeneration greatly amplified tau expression amino-terminally truncated pyroglutamylated pe forms amyloid-beta strongly associated alzheimers disease toxic amyloid-beta residues beta- beta- proposed initiators alzheimers disease pathogenesis report mechanism pe-a beta may trigger alzheimers disease betape- co-oligomerizes excess beta- form metastable low-n oligomers lnos structurally distinct far cytotoxic cultured neurons comparable lnos made beta- alone tau required cytotoxicity lnos comprising % betape- plus % beta- % pe-a beta seed new cytotoxic lnos multiple serial dilutions beta- monomers absence additional betape- lnos isolated human alzheimers disease brain contained betape- enhanced betape- formation mice triggered neuron loss gliosis months tau-null background conclude betape- confers tau-dependent neuronal death causes template-induced misfolding beta- structurally distinct lnos propagate prion-like mechanism results raise possibility betape- acts similarly primary step alzheimers disease pathogenesis
